Morgan Stanley’s Cellebrite CLBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $74.4M | Buy |
4,652,578
+689,319
| +17% | +$11M | ﹤0.01% | 1566 |
|
|
2025
Q1 | $77M | Sell |
3,963,259
-1,199,548
| -23% | -$23.3M | 0.01% | 1438 |
|
|
2024
Q4 | $114M | Sell |
5,162,807
-212,583
| -4% | -$4.68M | 0.01% | 1163 |
|
|
2024
Q3 | $90.5M | Sell |
5,375,390
-1,615,681
| -23% | -$27.2M | 0.01% | 1325 |
|
|
2024
Q2 | $83.5M | Buy |
6,991,071
+2,866,806
| +70% | +$34.3M | 0.01% | 1310 |
|
|
2024
Q1 | $45.7M | Sell |
4,124,265
-3,098,477
| -43% | -$34.3M | ﹤0.01% | 1843 |
|
|
2023
Q4 | $62.5M | Buy |
7,222,742
+4,887,849
| +209% | +$42.3M | ﹤0.01% | 2218 |
|
|
2023
Q3 | $17.9M | Buy |
2,334,893
+178,058
| +8% | +$1.36M | ﹤0.01% | 2577 |
|
|
2023
Q2 | $15.5M | Buy |
2,156,835
+38,330
| +2% | +$276K | ﹤0.01% | 2731 |
|
|
2023
Q1 | $12.9M | Sell |
2,118,505
-26,379
| -1% | -$161K | ﹤0.01% | 2895 |
|
|
2022
Q4 | $9.35M | Buy |
2,144,884
+2,140,900
| +53,737% | +$9.33M | ﹤0.01% | 3156 |
|
|
2022
Q3 | $15K | Sell |
3,984
-2,310
| -37% | -$8.7K | ﹤0.01% | 6914 |
|
|
2022
Q2 | $31K | Buy |
6,294
+69
| +1% | +$340 | ﹤0.01% | 6820 |
|
|
2022
Q1 | $40K | Sell |
6,225
-12,725
| -67% | -$81.8K | ﹤0.01% | 6800 |
|
|
2021
Q4 | $152K | Buy |
18,950
+12,617
| +199% | +$101K | ﹤0.01% | 6206 |
|
|
2021
Q3 | $58K | Buy |
+6,333
| New | +$58K | ﹤0.01% | 6646 |
|